Abstract
A novel series of 10-hydroxyl ketolide derivatives were synthesized, during which a distinctive intermediate, 3-O-descladinosyl-3-oxo-11-deoxy-10,11-epoxy-6-O-methylerythromycin A, was obtained from 6-O-methylerythromycin A. The structure and stereochemistry of this novel structure were confirmed via NMR and X-ray crystallography. Moreover, antibacterial evaluations were established in order to assess our modifications and acquire a deep understanding of the ketolides' structure-activity relationship (SAR).
Copyright © 2013 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / chemical synthesis*
-
Anti-Bacterial Agents / chemistry
-
Anti-Bacterial Agents / pharmacology
-
Bacteria / drug effects
-
Binding Sites
-
Clarithromycin / chemistry
-
Crystallography, X-Ray
-
Drug Evaluation, Preclinical
-
Ketolides / chemical synthesis
-
Ketolides / chemistry*
-
Ketolides / pharmacology
-
Magnetic Resonance Spectroscopy
-
Microbial Sensitivity Tests
-
Molecular Conformation
-
Molecular Docking Simulation
-
Peptidyl Transferases / chemistry
-
Peptidyl Transferases / metabolism
-
Protein Structure, Tertiary
-
Structure-Activity Relationship
Substances
-
Anti-Bacterial Agents
-
Ketolides
-
Peptidyl Transferases
-
Clarithromycin